Journal of Neuroimmunology
Volume 227, Issue 1 , Pages 190-194 , 8 October 2010

Natalizumab treatment reduces endothelial activity in MS patients

Received 11 May 2010 ,Revised 5 July 2010 ,Accepted 19 July 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0165-5728(10)00303-6

doi: 10.1016/j.jneuroim.2010.07.012

Journal of Neuroimmunology
Volume 227, Issue 1 , Pages 190-194 , 8 October 2010

Article Tools

* Image Usage & Resolution